JPS6231714B2 - - Google Patents

Info

Publication number
JPS6231714B2
JPS6231714B2 JP53077951A JP7795178A JPS6231714B2 JP S6231714 B2 JPS6231714 B2 JP S6231714B2 JP 53077951 A JP53077951 A JP 53077951A JP 7795178 A JP7795178 A JP 7795178A JP S6231714 B2 JPS6231714 B2 JP S6231714B2
Authority
JP
Japan
Prior art keywords
foam
benoxaprofen
forms
polymorphic
tablets
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP53077951A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5411224A (en
Inventor
Shaarotsuku Roi
Aran Hitsukusu Tarensu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lilly Industries Ltd
Original Assignee
Lilly Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Industries Ltd filed Critical Lilly Industries Ltd
Publication of JPS5411224A publication Critical patent/JPS5411224A/ja
Publication of JPS6231714B2 publication Critical patent/JPS6231714B2/ja
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/56Benzoxazoles; Hydrogenated benzoxazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D263/57Aryl or substituted aryl radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP7795178A 1977-06-28 1978-06-27 Improvement of benoxaprophene Granted JPS5411224A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB26907/77A GB1590587A (en) 1977-06-28 1977-06-28 Benoxaprofen

Publications (2)

Publication Number Publication Date
JPS5411224A JPS5411224A (en) 1979-01-27
JPS6231714B2 true JPS6231714B2 (cs) 1987-07-09

Family

ID=10251100

Family Applications (1)

Application Number Title Priority Date Filing Date
JP7795178A Granted JPS5411224A (en) 1977-06-28 1978-06-27 Improvement of benoxaprophene

Country Status (17)

Country Link
EP (1) EP0000276B1 (cs)
JP (1) JPS5411224A (cs)
AT (1) AT360008B (cs)
AU (1) AU518403B2 (cs)
BE (1) BE868522A (cs)
CH (1) CH631449A5 (cs)
DE (2) DE2828074A1 (cs)
DK (1) DK145419C (cs)
FI (1) FI69453C (cs)
FR (1) FR2396004A1 (cs)
GB (1) GB1590587A (cs)
IE (1) IE47009B1 (cs)
IL (1) IL55015A (cs)
IT (1) IT1105065B (cs)
LU (1) LU79879A1 (cs)
NZ (1) NZ187674A (cs)
ZA (1) ZA783660B (cs)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1435721A (en) * 1972-05-18 1976-05-12 Lilly Industries Ltd Benzoxazole derivatives
US3888864A (en) 1973-06-29 1975-06-10 Hoffmann La Roche Amino lower alkyl ether derivatives of opium alkaloids
GB1495488A (en) * 1976-06-23 1977-12-21 Ippco Int Pharma Patents Co Es Optically active 2-(2-phenyl-5-benzoxazolyl)propionic acids
IT1099589B (it) * 1978-08-04 1985-09-18 Ravizza Spa Processo per la preparazione di derivati dell'acido benzoxazolil propionico
IT1157295B (it) * 1982-07-19 1987-02-11 Ravizza Spa Processo perfezionato per la preparazione di derivati dell'acido benzoxazolil propionico
UA83620C2 (ru) 2001-12-05 2008-08-11 Уайт Замещенные бензоксазолы и их аналоги как эстрогенные агенты
WO2021116820A1 (en) * 2019-12-10 2021-06-17 Aurobindo Pharma Limited An improved process for the preparation of benoxaprofen
DE102022117931A1 (de) 2022-07-18 2024-01-18 HUECK System GmbH & Co. KG Profilanordnung mit wärmedämmung
US11981645B1 (en) 2023-10-10 2024-05-14 King Faisal University N′-(2-naphthoyloxy)-2-(benzo[d]oxazol-2-yl)acetimidamide as antimicrobial compound

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1435721A (en) * 1972-05-18 1976-05-12 Lilly Industries Ltd Benzoxazole derivatives
GB1488003A (en) * 1973-10-23 1977-10-05 Lilly Industries Ltd 1,2-benzisoxazole derivatives processes for their preparation and their use as pharmaceuticals
US4087437A (en) * 1976-09-07 1978-05-02 Eli Lilly And Company 2-Phenyl-5-benzoxazolylalkanoic acid purification process

Also Published As

Publication number Publication date
FI782043A7 (fi) 1978-12-29
IT7850048A0 (it) 1978-06-27
EP0000276A1 (en) 1979-01-10
EP0000276B1 (en) 1982-09-01
IE47009B1 (en) 1983-11-30
GB1590587A (en) 1981-06-03
ZA783660B (en) 1979-06-27
DK145419B (da) 1982-11-15
LU79879A1 (cs) 1978-12-07
AT360008B (de) 1980-12-10
DE2862013D1 (en) 1982-10-28
DK145419C (da) 1983-04-18
FI69453B (fi) 1985-10-31
DK287578A (da) 1978-12-29
IE781277L (en) 1978-12-28
NZ187674A (en) 1980-11-14
IT1105065B (it) 1985-10-28
FR2396004A1 (fr) 1979-01-26
CH631449A5 (fr) 1982-08-13
IL55015A0 (en) 1978-08-31
ATA466178A (de) 1980-05-15
IL55015A (en) 1981-11-30
FI69453C (fi) 1986-02-10
JPS5411224A (en) 1979-01-27
DE2828074A1 (de) 1979-01-11
AU3750178A (en) 1980-01-03
AU518403B2 (en) 1981-10-01
BE868522A (fr) 1978-12-27
FR2396004B1 (cs) 1981-09-18

Similar Documents

Publication Publication Date Title
US5612367A (en) Method of enhancing bioavailability of pharmaceutical agents
JP2009280604A (ja) N−(4−トリフルオロメチルフェニル)−5−メチルイソオキサゾール−4−カルボキサミドの結晶形態の製造方法
CN101412700B (zh) 非布司他的晶型及其制备方法
JP6720280B2 (ja) 新規アベキシノスタット塩、関連結晶形態、それらの調製方法およびそれらを含有する医薬組成物
HU196775B (en) Process for production of morfologically unique new modifications of famotidin and medical compositions containing such substances
JPH0739405B2 (ja) 2−エトキシ−4−〔n−(1−(2−ピペリジノ−フエニル)−3−メチル−1−ブチル)−アミノカルボニルメチル〕安息香酸の新しい固体型
JPS6231714B2 (cs)
UA72333C2 (en) Form(r)-n-[5-methyl-8-(4-methylpiperazine-1-yl)-1,2,3,4,-tetrahydro-2-naphthyl]-4-morfolinobenzamide
WO2016078543A1 (zh) 一种盐酸洛氟普啶多晶型物及其制备方法
KR20010013127A (ko) 신규 염
AU3095600A (en) New pharmaceutical formulation
CN105646320A (zh) 一种稳定的维纳卡兰化合物
CN116239592A (zh) 一种阿哌沙班与没食子酸共晶溶剂合物
WO2014193881A1 (en) Crystalline form of n,n-dicyclopropyl-4-(1,5-dimethyl-1 h-pyrazol-3-ylamino)-6-ethyl-1 -methyl-1,6-dihyrdroimidazo[4,5-d]pyrrolo[2,3-b]pyridine-7-carboxamide for the treatment of myeloproliferative disorders
JPS5910660B2 (ja) 5−ベンゾイルインドリン−2−オンの製造方法
US5872125A (en) Polymorphs of lesopitron dihydrochloride and its hydrated forms, preparation processes and compositions containing it
WO2007131444A1 (fr) Nouvelle forme cristallographique du composé 3,4',5-trihydroxyl-stilbène-3-bêta-d-glucoside
HU220769B1 (hu) N-[ 4-(5-/Ciklopentil-oxi-karbonil-amino/-l-metil-indol-3-il-metil)-3-metoxi-benzoil]-2-metil-benzolszulfonamid új fizikai módosulata és eljárás annak előállítására
CN106554376B (zh) 吗啡衍生物晶型ii及其制备方法和用途
NO179575B (no) Farmasöytisk preparat inneholdende en fysikalsk form av forbindelsen N-[4-[5-(cyklopentyloksykarbonyl)amino-1-metylindol-3-ylmetyl-3-metoksybenzoylÅ-2-metylbenzensulfonamid
JPS5916820A (ja) 無晶形マロチラ−トを含有する固形製剤組成物
AU3041699A (en) Crystalline forms of 1S-(1alpha (2S*,3R*), 9alpha)-6, 10-dioxo-N- (2-ethoxy-5 -oxo-tetrahydro-3 -furanyl) -9-(((1-isoquinolyl) carbonyl)-amino) octahydro-6H -piridazino(1, 2-A)(1,2) diazepin- 1-carboxamide
JP2009527544A (ja) ベシピルジン塩酸塩の結晶形態、その製造方法および使用
PT100508B (pt) Composicoes farmaceuticas e processo para a sua preparacao
MXPA98001705A (en) Form of alternate glass of the tazofel